The rising price for the EpiPen, a drug delivery system that is crucial for persons experiencing potentially life-threatening allergic reactions, has resulted in outrage. The price increase, from about $94 for a two-pack of injectable epinephrine to more than $600 in just nine years, has members of Congress calling for investigations regarding how Mylan, the drug’s manufacturer, can justify this increase. In the last year alone, the price has climbed by $200.

 …